HS code: 30
To | |
Direction | |
From | |
Period | |
Selection products |
Period | Total |
---|---|
2018 | $30.1 K |
2019 | $16.2 K |
Total: | $46.4 K |
Period | Weight, tons. |
---|---|
2018 | 0.329 |
2019 | 0.13 |
Total: | 0.459 |
Group product | 2018 | 2019 | Ch. | ∑ (2018-2019) | Ratio |
---|---|---|---|---|---|
06 3001: Glands and other organs for organo-therapeutic uses | --- | --- | --- | --- | 0% |
06 3002: Human blood; animal blood; vaccines, toxins, cultures of micro-organisms and similar products | --- | --- | --- | --- | 0% |
06 3003: Medicaments consisting of two or more constituents, for retail sale | --- | --- | --- | --- | 0% |
06 3004: Medicaments consisting of mixed or unmixed products for retail sale | --- | --- | --- | --- | 0% |
06 3005: Wadding, gauze, bandages and similar articles | $30.1 K | $16.2 K | 46% | $46.4 K | 100% |
06 3006: Pharmaceutical goods specified in note 4 to this chapter | --- | --- | --- | --- | 0% |
Total: | $30.1 K | $16.2 K | $46.4 K |
№ | Country | ∑ (2018-2019) | Ratio |
---|---|---|---|
1 | India | $2.1 M | 18.7% |
2 | Belarus | $2.1 M | 18.1% |
3 | Germany | $1.8 M | 15.6% |
4 | Croatia | $1.5 M | 12.9% |
5 | China | $1.1 M | 9.4% |
6 | Egypt | $880 K | 7.7% |
7 | United Kingdom | $577 K | 5% |
8 | Kazakhstan | $353 K | 3.1% |
9 | Greece | $333 K | 2.9% |
10 | United States | $285 K | 2.5% |
11 | Ukraine | $134 K | 1.2% |
12 | Kyrgyzstan | $92.7 K | 0.8% |
13 | Pakistan | $85.5 K | 0.7% |
14 | Spain | $51.1 K | 0.4% |
15 | Armenia | $49.2 K | 0.4% |
16 | Finland | $46.4 K | 0.4% |
17 | Austria | $15.8 K | 0.1% |
18 | France | $2.66 K | 0% |
19 | Japan | $519 | 0% |
The total for all countries: | $11.5 M | 100% |
№ | Region | ∑ (2018-2019) | Ratio |
---|---|---|---|
1 | Moskva | $97.7 M | 66.5% |
2 | Sankt-Peterburg | $25.6 M | 17.4% |
3 | Moskovskaya oblast | $17.3 M | 11.8% |
4 | Kalujskaya oblast | $4.2 M | 2.9% |
5 | Nijegorodskaya oblast | $2.1 M | 1.4% |
6 | Novosibirskaya oblast | $55.6 K | 0% |
7 | Samarskaya oblast | $46.4 K | 0% |
8 | Rostovskaya oblast | $189 | 0% |
By all regions: | $147 M | 100% |